Results 121 to 130 of about 2,941 (215)

bloodAGENT: a versatile tool for blood group typing and genomic variation analysis. [PDF]

Bioinform Adv
Wittig M, Steiert TA, Gassner C, Franke A.   +3 more
europepmc   +1 more source

Elastic Taping of the Toes after Percutaneous Forefoot Surgery: A Technical Tip. [PDF]

Foot Ankle Orthop
Toepfer A, Potocnik P, Farei-Campagna J, Ferraz Ferreira G, Nunes GA, Lewis TL, Lam P, Abdelatif NMN, Del Vecchio JJ.   +8 more
europepmc   +1 more source

The urgent need for biosecurity education within the agribusiness sector. [PDF]

Front Microbiol
Ibbotson O, Shang L.
europepmc   +1 more source

Orthoplastic tarsal reconstruction using a chimeric vascularized bone graft in a heavy smoker: a case report. [PDF]

J Surg Case Rep
Potocnik P, Lotter L, Toepfer A, Schmidt VJ.   +3 more
europepmc   +1 more source

Merging High-Throughput, Amplicon-Based Second and Third Generation Sequencing Data: An Integrative and Modular Data Analysis Framework for Haplotype Prediction and Output Evaluation. [PDF]

Int J Mol Sci
Mink S, Attenberger C, Busch Y, Kiefer J, Peter W, Cadamuro J, Steiert TA, Franke A, Gassner C.   +8 more
europepmc   +1 more source

The Development of the Criminal Procedure in the Principality of Liechtenstein

Ugolovnaya yustitsiya, 2020
openaire   +1 more source

NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data. [PDF]

ESMO Open
Reichinger A, Friedrich A, Lentner T, Taghizadeh H, Reimann P, Nothdurfter D, Burghofer J, Windhager H, Kirchweger P, Webersinke G, Winder T, Rumpold H, Doleschal B, Prager GW.   +13 more
europepmc   +1 more source

Educational maintenance allowance: educational maintenance allowance (Wales) regulations 2007 : consultation [PDF]

, 2007

core  

Comparison of sugammadex or neostigmine for reversal of mild rocuronium paralysis using repetitive 100-Hz tetanic fade. [PDF]

Br J Anaesth
Debaene B, Frasca D, Moreillon F, D'Hollander AA.   +3 more
europepmc   +1 more source

Exploring the impact of first-line durvalumab plus chemotherapy on advanced biliary tract cancer: a systematic review and meta-analysis. [PDF]

Oncologist
Reimann P, Schneider EM, Djanani A, Mink S, Winder T, Benda M.   +5 more
europepmc   +1 more source